BioWorld

Oct. 3, 2003

View Archived Issues

Genetic Model Company GenPath Raises $42.7M In Series B Round

Little more than a year after starting a business based on spontaneous tumor models in mice, GenPath Pharmaceuticals Inc. raised $42.7 million in a Series B financing. (BioWorld Today) Read More

Nuvelo Raises $24.5M For Alfimeprase, In-Licensing

Read More

French Scientists Win Where Others Lost, Cloning Robust Rat Colony To Make Drugs Against Major Diseases

Read More

Biosyn Eyeing $10M For HIV Product Development Program

Read More

Other News To Note

Read More